α-methylacyl-CoA racemase: A new molecular marker for prostate cancer

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2220-2226

  Luo, Jun ^a   Zha, Shan ^a   Gage, Wesley R ^a   Dunn, Thomas A ^a   Hicks, Jessica L ^a   Bennett, Christina J ^a   Ewing, Charles M ^a   Platz, Elizabeth A ^b   Ferdinandusse, Sacha ^d   Wanders, Ronald J ^d   Trent, Jeffrey M ^c   Isaacs, William B ^a   de Marzo, Angelo M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; COMPLEMENTARY DNA; FATTY ACID; MESSENGER RNA; MOLECULAR MARKER; PROTEIN P63; RACEMASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; ENZYME LOCALIZATION; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PEROXISOME; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; RNA, MESSENGER; STAINING AND LABELING; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 17344393447     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prostate cancer
2. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
3. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
4. Expression profiling reveals hepsin overexpression in prostate cancer
5. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray
6. Delineation of prognostic biomarkers in prostate cancer
7. Subcellular localization and physiological role of α-methylacyl-CoA racemase
8. Refsum disease
9. Dairy products, calcium, and prostate cancer risk in the Physicians' health study
10. Peroxisomal fatty acid α- and β-oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases
11. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis
12. Neoplastic conversion of human urothelial cells in vitro by overexpression of H202-generating peroxisomal fatty acyl CoA oxidase
13. p63 is a prostate basal cell marker and is required for prostate development
14. Expression of p63 in normal, neoplastic and preneoplastic human prostate tissues
15. Methods of radical prostatectomy specimen processing: A novel technique for harvesting fresh prostate cancer tissue and review of processing techniques
16. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma
17. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: The prostate specialized program of research excellence model
18. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens
19. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
20. Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma
21. The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies
22. The utility of basal cell-specific anti-cytokeratin antibody (34 β E12) in the diagnosis of prostate cancer. A review of 228 cases
23. Microcarcinoma in the prostate: Its association with duct-acinar dysplasia
24. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
25. Characterization of two steroidal ketones and two isoprenoid alcohols in dairy products
26. In vivo visualization of gene expression using magnetic resonance imaging
27. P504S: A new molecular marker for the detection of prostate carcinoma